The People Behind the
Mission
Meet the leadership team driving PanGIA Biotech’s mission to transform early cancer detection worldwide.
PanGIA Biotech’s executive team brings together deep experience in science, strategy, and healthcare innovation.
With a shared commitment to accessibility and equity, they are pioneering non-invasive diagnostics that reimagine what’s possible in early cancer detection.
Holly Magliocchetti
CEO
& Co-Founder
Robert Cardwell
Chief Strategy Officer
& Co-Founder
Obdulio Piloto, Ph.D.
Chief Scientific Officer
& Co-Founder
A pioneer in AI-driven diagnostics, Dr. Piloto leads scientific development at PanGIA Biotech. His expertise in biomolecular profiling underpins the company’s innovative approach to accurate, non-invasive cancer detection.
Joseph Frattaroli, CPA
Chief Financial Officer
With over two decades of financial leadership in biopharma, Joseph provides PanGIA Biotech with strategic guidance across capital formation, IPO readiness, and public company compliance—laying a strong financial foundation for scale, credibility, and sustained growth.
Curtiss McNair
Vice President
of Operations
With a background in healthcare and biotech operations, Curtiss ensures PanGIA Biotech’s daily execution aligns with its strategic vision. He focuses on optimizing processes, supporting regulatory readiness, and building infrastructure for scale and clinical delivery.